48:I[501251,["/_next/static/immutable/chunks/1vj4trnw9w9nm.js","/_next/static/immutable/chunks/00rrbr13kmv1p.js","/_next/static/immutable/chunks/1ck0jx1-b89ut.js","/_next/static/immutable/chunks/0uh6s6emb9gec.js","/_next/static/immutable/chunks/1k5oa3vex4vr7.js","/_next/static/immutable/chunks/1d1t0gdxze6p0.js","/_next/static/immutable/chunks/25du2jdpejesu.js","/_next/static/immutable/chunks/0k3qj4pethwnu.js","/_next/static/immutable/chunks/18rfpymc0lszy.js","/_next/static/immutable/chunks/41dc2d9ynqsar.js","/_next/static/immutable/chunks/3sh-5ggfo8-o-.js","/_next/static/immutable/chunks/1xd82xtq8lmqr.js","/_next/static/immutable/chunks/2adxzy6mbwp-x.js","/_next/static/immutable/chunks/3lgtqhnuy55ky.js","/_next/static/immutable/chunks/1cnb5h1vue9bh.js","/_next/static/immutable/chunks/2zixdggpqhsvg.js","/_next/static/immutable/chunks/2n54qkuvpodjb.js","/_next/static/immutable/chunks/0h9ddbh1wlgl2.js","/_next/static/immutable/chunks/1rs8grdvu-9rj.js","/_next/static/immutable/chunks/1jz3adntho04d.js","/_next/static/immutable/chunks/07csm-6lkvbtx.js","/_next/static/immutable/chunks/0wx9hn75dw89b.js","/_next/static/immutable/chunks/35w1vbxm8is6r.js","/_next/static/immutable/chunks/36j-_mvtvvrvw.js","/_next/static/immutable/chunks/25g6kb_imnv-z.js","/_next/static/immutable/chunks/2vmqd9tn2lz93.js","/_next/static/immutable/chunks/0vzz9hao18d--.js","/_next/static/immutable/chunks/0t51qo4jljg2d.js","/_next/static/immutable/chunks/114d3bu0vv_ut.js","/_next/static/immutable/chunks/022r2e5zzpzi_.js","/_next/static/immutable/chunks/3x6_1d8sez913.js","/_next/static/immutable/chunks/0ckcxr_-l-g6r.js","/_next/static/immutable/chunks/0fzn2vwvie6by.js","/_next/static/immutable/chunks/0fml8wdjdhhjx.js","/_next/static/immutable/chunks/0l-_felc50tfb.js","/_next/static/immutable/chunks/217d27shh98tw.js","/_next/static/immutable/chunks/2x03jtn4ys_wx.js","/_next/static/immutable/chunks/106okwxokaihl.js","/_next/static/immutable/chunks/3nmorw-z1v1_j.js","/_next/static/immutable/chunks/3y8tezs0d4voy.js","/_next/static/immutable/chunks/14te8jxjcp-rk.js","/_next/static/immutable/chunks/2cb8ta0cw16tv.js","/_next/static/immutable/chunks/1_l1rb7jhninj.js","/_next/static/immutable/chunks/31c3o7hocgex3.js"],"JobCard"] 4e:I[399822,["/_next/static/immutable/chunks/1vj4trnw9w9nm.js","/_next/static/immutable/chunks/00rrbr13kmv1p.js","/_next/static/immutable/chunks/1ck0jx1-b89ut.js","/_next/static/immutable/chunks/0uh6s6emb9gec.js","/_next/static/immutable/chunks/1k5oa3vex4vr7.js","/_next/static/immutable/chunks/1d1t0gdxze6p0.js","/_next/static/immutable/chunks/25du2jdpejesu.js","/_next/static/immutable/chunks/0k3qj4pethwnu.js","/_next/static/immutable/chunks/18rfpymc0lszy.js","/_next/static/immutable/chunks/41dc2d9ynqsar.js","/_next/static/immutable/chunks/3sh-5ggfo8-o-.js","/_next/static/immutable/chunks/1xd82xtq8lmqr.js","/_next/static/immutable/chunks/2adxzy6mbwp-x.js","/_next/static/immutable/chunks/3lgtqhnuy55ky.js","/_next/static/immutable/chunks/1cnb5h1vue9bh.js","/_next/static/immutable/chunks/2zixdggpqhsvg.js","/_next/static/immutable/chunks/2n54qkuvpodjb.js","/_next/static/immutable/chunks/0h9ddbh1wlgl2.js","/_next/static/immutable/chunks/1rs8grdvu-9rj.js","/_next/static/immutable/chunks/1jz3adntho04d.js","/_next/static/immutable/chunks/07csm-6lkvbtx.js","/_next/static/immutable/chunks/0wx9hn75dw89b.js","/_next/static/immutable/chunks/35w1vbxm8is6r.js","/_next/static/immutable/chunks/36j-_mvtvvrvw.js","/_next/static/immutable/chunks/25g6kb_imnv-z.js","/_next/static/immutable/chunks/2vmqd9tn2lz93.js","/_next/static/immutable/chunks/0vzz9hao18d--.js","/_next/static/immutable/chunks/0t51qo4jljg2d.js","/_next/static/immutable/chunks/114d3bu0vv_ut.js","/_next/static/immutable/chunks/022r2e5zzpzi_.js","/_next/static/immutable/chunks/3x6_1d8sez913.js","/_next/static/immutable/chunks/0ckcxr_-l-g6r.js","/_next/static/immutable/chunks/0fzn2vwvie6by.js","/_next/static/immutable/chunks/0fml8wdjdhhjx.js","/_next/static/immutable/chunks/0l-_felc50tfb.js","/_next/static/immutable/chunks/217d27shh98tw.js","/_next/static/immutable/chunks/2x03jtn4ys_wx.js","/_next/static/immutable/chunks/106okwxokaihl.js","/_next/static/immutable/chunks/3nmorw-z1v1_j.js","/_next/static/immutable/chunks/3y8tezs0d4voy.js","/_next/static/immutable/chunks/14te8jxjcp-rk.js","/_next/static/immutable/chunks/2cb8ta0cw16tv.js","/_next/static/immutable/chunks/1_l1rb7jhninj.js","/_next/static/immutable/chunks/31c3o7hocgex3.js"],"JobsSearchShell"] 4f:I[481774,["/_next/static/immutable/chunks/1vj4trnw9w9nm.js","/_next/static/immutable/chunks/00rrbr13kmv1p.js","/_next/static/immutable/chunks/1ck0jx1-b89ut.js","/_next/static/immutable/chunks/0uh6s6emb9gec.js","/_next/static/immutable/chunks/1k5oa3vex4vr7.js","/_next/static/immutable/chunks/1d1t0gdxze6p0.js","/_next/static/immutable/chunks/25du2jdpejesu.js","/_next/static/immutable/chunks/0k3qj4pethwnu.js","/_next/static/immutable/chunks/18rfpymc0lszy.js","/_next/static/immutable/chunks/41dc2d9ynqsar.js","/_next/static/immutable/chunks/3sh-5ggfo8-o-.js","/_next/static/immutable/chunks/1xd82xtq8lmqr.js","/_next/static/immutable/chunks/2adxzy6mbwp-x.js","/_next/static/immutable/chunks/3lgtqhnuy55ky.js","/_next/static/immutable/chunks/1cnb5h1vue9bh.js","/_next/static/immutable/chunks/2zixdggpqhsvg.js","/_next/static/immutable/chunks/2n54qkuvpodjb.js","/_next/static/immutable/chunks/0h9ddbh1wlgl2.js","/_next/static/immutable/chunks/1rs8grdvu-9rj.js","/_next/static/immutable/chunks/1jz3adntho04d.js","/_next/static/immutable/chunks/07csm-6lkvbtx.js","/_next/static/immutable/chunks/0wx9hn75dw89b.js","/_next/static/immutable/chunks/35w1vbxm8is6r.js","/_next/static/immutable/chunks/36j-_mvtvvrvw.js","/_next/static/immutable/chunks/25g6kb_imnv-z.js","/_next/static/immutable/chunks/2vmqd9tn2lz93.js","/_next/static/immutable/chunks/0vzz9hao18d--.js","/_next/static/immutable/chunks/0t51qo4jljg2d.js","/_next/static/immutable/chunks/114d3bu0vv_ut.js","/_next/static/immutable/chunks/022r2e5zzpzi_.js","/_next/static/immutable/chunks/3x6_1d8sez913.js","/_next/static/immutable/chunks/0ckcxr_-l-g6r.js","/_next/static/immutable/chunks/0fzn2vwvie6by.js","/_next/static/immutable/chunks/0fml8wdjdhhjx.js","/_next/static/immutable/chunks/0l-_felc50tfb.js","/_next/static/immutable/chunks/217d27shh98tw.js","/_next/static/immutable/chunks/2x03jtn4ys_wx.js","/_next/static/immutable/chunks/106okwxokaihl.js","/_next/static/immutable/chunks/3nmorw-z1v1_j.js","/_next/static/immutable/chunks/3y8tezs0d4voy.js","/_next/static/immutable/chunks/14te8jxjcp-rk.js","/_next/static/immutable/chunks/2cb8ta0cw16tv.js","/_next/static/immutable/chunks/1_l1rb7jhninj.js","/_next/static/immutable/chunks/31c3o7hocgex3.js"],"JobsListProgressiveEnhancer"] 49:T181c,Salary Range: £84,490.00 - £156,910.00 Job Description Summary Director, AI Search and Visibility #LI-Hybrid Location: London Relocation Support: Yes Are you ready to reimagine medicine for patients? A new role has been created as part of our Customer Experience and Content Team. The Director AI Search and Visibility will be accountable for maximizing the visibility, discoverability, and relevance of Novartis content across AI-powered search ecosystems and traditional search environments. The role focuses on defining and executing the organization’s Search Engine Optimisation (SEO), GEO, and AI search strategy, ensuring that content is structured, optimized, and distributed to perform effectively across search engines, LLMs, and emerging discovery platforms. Job Description Key Responsibilities: - Define and lead the AI Search & SEO strategy across owned and earned channels, ensuring strong visibility in both traditional search engines and AI-driven discovery platforms (LLMs, assistants, generative search). - Establish and implement GEO (Generative Engine Optimization) principles to improve how Novartis content is surfaced, interpreted, and reused by AI systems. - Optimize content structure, tagging, and taxonomy to ensure machine readability, modularity, and reusability across search and omnichannel ecosystems. - Partner with Content, Web, and Omnichannel teams to ensure all content is search-optimized by design , not retrofitted. - Define and track AI search visibility metrics , including presence in LLM-generated responses, featured content surfaces, and search rankings. - Lead experimentation and innovation in AI search , including prompt optimization, structured content frameworks, and emerging discovery formats. - Collaborate with Data & Analytics teams to integrate search performance insights into omnichannel planning and content strategy . - Ensure alignment with compliance, governance, and brand standards in all search and AI-related optimization activities. - Build internal capability and awareness around AI search trends, risks, and opportunities , positioning Novartis as a leader in this space. Essential Requirements: - 10–12 years of relevant experience in technology development. - Strong experience with search engine optimisation - Experience working in Agile delivery models, including backlog management, sprint planning, and collaboration with global stakeholders. - Strong stakeholder management and communication skills, with the ability to influence senior leaders and align priorities across markets. - Proven ability to lead cross-functional teams in global or multi-market environments. - Excellent facilitation and executive-level communication skills and driving decisions Benefits & Rewards At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen. Expected Annual Base Salary Range for role: 84,490.00 - 156,910.00 GBP The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically. In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave. In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters . Long-term equity awards granted at group level may also be part of your package. Further details will be provided during the application process. You may be eligible for a company vehicle or a car allowance in accordance with the applicable local Novartis policies and guidelines. Pay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics. Read our brochure to learn more about our global total rewards offering: https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf Note: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. A full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the application process. Commitment to Diversity and Inclusion Novartis is committed to building an outstanding, inclusive work environment and diverse teams’ representative of the patients and communities we serve. Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people working together—collaborating, supporting, and inspiring one another—to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture Benefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards Skills Desired Brand Analysis, Brand Awareness, Commercial Excellence, Cross-Functional Collaboration, Customer Engagement, Customer Insights, Digital Marketing, Influencing Skills, Inspirational Leadership, Media Campaigns, People Management, Product Marketing, Product Roadmap, Return on Investment (ROI), Stakeholder Engagement, Stakeholder Management, Thought Leadership, Trend Analysis4a:Taee,

Responsibilities

Define and lead the AI Search & SEO strategy across owned and earned channels, ensuring strong visibility in both traditional search engines and AI-driven discovery platforms (LLMs, assistants, generative search).
Establish and implement GEO (Generative Engine Optimization) principals to improve how Novartis content is surfaced, interpreted, and reused by AI systems.
Optimize content structure, tagging, and taxonomy to ensure machine readability, modularity, and reusability across search and omnichannel ecosystems.
Partner with Content, Web, and Omnichannel teams to ensure all content is search-optimized by design , not retrofitted.
Define and track AI search visibility metrics , including presence in LLM-generated responses, featured content surfaces, and search rankings.
Lead experimentation and innovation in AI search , including prompt optimization, structured content frameworks, and emerging discovery formats.
Collaborate with Data & Analytics teams to integrate search performance insights into omnichannel planning and content strategy .
Ensure alignment with compliance, governance, and brand standards in all search and AI-related optimization activities.
Build internal capability and awareness around AI search trends, risks, and opportunities , positioning Novartis as a leader in this space.

Requirements

10–12 years of relevant experience in technology development.
Strong experience with search engine optimisation
Experience working in Agile delivery models, including backlog management, sprint planning, and collaboration with global stakeholders.
Strong stakeholder management and communication skills, with the ability to influence senior leaders and align priorities across markets.
Proven ability to lead cross-functional teams in global or multi-market environments.
Excellent facilitation and executive-level communication skills and driving decisions

Benefits

The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs.
we also offer flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.
Long-term equity awards granted at group level may also be part of your package. Further details will be provided during the application process.
You may be eligible for a company vehicle or a car allowance in accordance with the applicable local Novartis policies and guidelines.

45:["$","div",null,{"className":"flex-1 relative md:px-6 lg:px-10 xl:px-16","children":["$","div",null,{"className":"h-full flex max-w-[1200px] md:mx-auto","children":["$","div",null,{"className":"grid w-full grid-cols-1 gap-8 px-4 pb-12 md:px-0 lg:grid-cols-12","children":[["$","div",null,{"className":"flex min-w-0 flex-col gap-3 lg:col-span-12","children":[["$","p",null,{"data-slot":"text","className":"text-gray-600 dark:text-gray-300 text-surface-body leading-normal tracking-normal py-1.5","children":"2 jobs"}],["$","div",null,{"className":"flex flex-col gap-3","children":[["$","$L24","7f6f95f0-aacb-49de-9c7f-1b6e53e5d277",{"href":"/uk/jobs/director-ai-search-visibility-novartis-7f6f95","target":"_blank","rel":"noopener","prefetch":false,"data-job-id":"7f6f95f0-aacb-49de-9c7f-1b6e53e5d277","className":"block rounded-surface focus-visible:outline-2 focus-visible:outline-offset-2 focus-visible:outline-emerald-600","children":[["$","$L48",null,{"job":{"id":"7f6f95f0-aacb-49de-9c7f-1b6e53e5d277","externalId":"2439385867","isActive":"$undefined","expiredAt":null,"slug":"director-ai-search-visibility-novartis-7f6f95","title":"Director AI Search & Visibility","company":{"name":"Novartis","id":"58f13048-3c78-4181-a66c-ffbf4c623801","slug":"novartis","logo":"https://gtyykqgsrkbjbjkkjsak.supabase.co/storage/v1/object/public/logos/companies/novartis.jpg","url":null,"employees":82428,"founded":1996,"type":"In-house","industry":"Biotechnology","industries":["Biotechnology","Health Care","Medical","Pharmaceutical","Precision Medicine","Robotics"],"business_model":"Other","logoUpdatedAt":null,"updatedAt":null},"location":{"display":"London, UK","remote":false,"workArrangement":"hybrid","locations":[],"typedId":null,"tooltip":null,"typedKind":null,"typedName":null,"typedCountryCode":null,"typedSlug":"london","typedUrlPath":"united-kingdom/london","hierarchyIds":null},"seniority":"Director/Executive","experienceYears":10,"salary":{"min":84490,"max":156910,"currency":"GBP","unit":"YEAR","display":"£84K/yr – £157K/yr"},"estimatedSalary":null,"employment":{"types":["Full time"]},"dates":{"posted":"2026-10-29T00:00:00.000Z","postedRelative":"1 day ago","validThrough":null},"description":{"text":"$49","html":"$4a"},"applyUrl":"https://novartis.wd3.myworkdayjobs.com/Novartis_Careers/job/London-The-Westworks/Director-AI-Search---Visibility_REQ-10091139","applyType":"ats","source":"ats","subcategory":"AI Search","subcategories":["AI Search"],"jobCategory":null,"isEasyApply":false,"companyProfile":{"id":"58f13048-3c78-4181-a66c-ffbf4c623801","name":"Novartis","slug":"novartis","logo_url":"https://gtyykqgsrkbjbjkkjsak.supabase.co/storage/v1/object/public/logos/companies/novartis.jpg","crunchbase_url":"https://crunchbase.com/organization/novartis","website":"http://www.novartis.com","linkedin_identifier":null,"linkedin_url":"https://www.linkedin.com/company/novartis","x_url":"http://twitter.com/novartis","industry":"Biotechnology","type":"In-house","size":null,"headquarters_city":"Münchenstein","headquarters_state":"Basel-Country","headquarters_country":"CHE","description":"Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki","employee_count":82428,"founded":1996,"business_model":"Other","industries":["Biotechnology","Health Care","Medical","Pharmaceutical","Precision Medicine","Robotics"],"headcount_by_role":{"Legal":2199,"Sales":10465,"Finance":2761,"Support":1709,"Research":10322,"Education":1605,"Marketing":2180,"Accounting":956,"Consulting":718,"Operations":8413,"Purchasing":545,"Engineering":3186,"Real Estate":133,"Administrative":2071,"Arts and Design":850,"Human Resources":1984,"Entrepreneurship":320,"Quality Assurance":3106,"Product Management":748,"Healthcare Services":4898,"Business Development":6763,"Information Technology":4833,"Media and Communication":1295,"Customer Success and Support":1502,"Community and Social Services":825,"Program and Project Management":2665,"Military and Protective Services":474}},"aiSummary":"

Own and drive the AI Search and SEO strategy across owned and earned channels, build GEO-based optimization, and lead cross-functional collaboration to improve AI-driven visibility while ensuring compliance and brand standards.

","employeeSentiment":null,"trafficSignals":{"monthlyGoogleAdsBudget":51830,"monthlyVisitors":1147928,"trafficSources":[{"label":"Search","percent":49.65257707981296},{"label":"Direct","percent":34.16885384354713},{"label":"Referral","percent":9.616775207963856},{"label":"Social","percent":5.500196384694195},{"label":"Paid","percent":0.932562251747448}]},"growthSignals":{"currentHeadcount":82574,"trend":[{"label":"2024-01-29 00:00:00","headcount":74287},{"label":"2024-02-26 00:00:00","headcount":74341},{"label":"2024-03-25 00:00:00","headcount":74418},{"label":"2024-04-29 00:00:00","headcount":74400},{"label":"2024-05-27 00:00:00","headcount":74634},{"label":"2024-06-24 00:00:00","headcount":74800},{"label":"2024-07-29 00:00:00","headcount":74957},{"label":"2024-08-26 00:00:00","headcount":75218},{"label":"2024-09-30 00:00:00","headcount":75589},{"label":"2024-10-28 00:00:00","headcount":76032},{"label":"2024-11-25 00:00:00","headcount":76479},{"label":"2024-12-30 00:00:00","headcount":76437},{"label":"2025-01-27 00:00:00","headcount":76951},{"label":"2025-02-24 00:00:00","headcount":77247},{"label":"2025-03-31 00:00:00","headcount":77615},{"label":"2025-04-28 00:00:00","headcount":77960},{"label":"2025-05-26 00:00:00","headcount":78288},{"label":"2025-06-30 00:00:00","headcount":78836},{"label":"2025-07-28 00:00:00","headcount":79422},{"label":"2025-08-25 00:00:00","headcount":80076},{"label":"2025-09-29 00:00:00","headcount":80741},{"label":"2025-10-27 00:00:00","headcount":81732},{"label":"2025-11-24 00:00:00","headcount":82308},{"label":"2025-12-08 00:00:00","headcount":82574}]},"marketingTeam":{"stats":[{"label":"Marketing Team Size","value":"3,475 (4% of company)","note":null},{"label":"Median Career Experience","value":"19 years","note":null},{"label":"Median Tenure","value":"5.2 years","note":null},{"label":"Marketing Roles Posted (Last 30 Days)","value":"5","note":null}]},"people":{"founderCeo":[{"personId":"99690","name":"Vas Narasimhan","title":"Chief Executive Officer","linkedInUrl":"https://www.linkedin.com/in/vasnarasimhan","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/c89ee172ac3ecc46c00ddeab1dd04b7fbf8f88eef64dbac1e31c0978a2daf556.jpg","metaTitle":"At the company for","metaValue":"At the company for 21 years 7 months"}],"hrRecruitment":[{"personId":"90984254","name":"Nicholas Cattafi","title":"Talent Acquisition Business Partner - Global Functions","linkedInUrl":"https://www.linkedin.com/in/nicholas-cattafi-42371510","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/bdcba9fb2da73d72a36c8df134bf4c5ad3da31bd7c48265ae671e91c26f7e4c5.jpg","metaTitle":"At the company for","metaValue":"At the company for 1 year 2 months"},{"personId":"153408065","name":"Akash George","title":"Senior Talent Acquisition Business Partner","linkedInUrl":"https://www.linkedin.com/in/akash-george-48a760138","photoUrl":"","metaTitle":"At the company for","metaValue":"At the company for 3 years 4 months"}],"marketingLeadership":[{"personId":"2933942","name":"Sarita T. Finnie","title":"Vice President, Marketing - Cardiovascular","linkedInUrl":"https://www.linkedin.com/in/sarita-t-finnie","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/06002da82d32453d5ea6d95d02cdfd9722d95010eb2b9a3b2a7318f703c898c5.jpg","metaTitle":"At the company for","metaValue":"At the company for 9 months"},{"personId":"2571713","name":"Matt Sabino","title":"Vice President, Marketing Immunology","linkedInUrl":"https://www.linkedin.com/in/matt-sabino-8532156","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/e2deaf2521bad6cba2ffd09f06c0bf7eeabfdeb5b1a658a7fc3b690be7cd8ebf.jpg","metaTitle":"At the company for","metaValue":"At the company for 25 years"},{"personId":"121167257","name":"Weina Wang","title":"VP, Marketing Strategy, Radioligand Therapy, US Oncology","linkedInUrl":"https://www.linkedin.com/in/weinawang","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/9d89f869d6665aa3b553c8a631b6f7f3b962077933e8175c5b2bae600328e838.jpg","metaTitle":"At the company for","metaValue":"At the company for 9 years 5 months"},{"personId":"2413408","name":"Aliah Davis-McHenry","title":"Global Head (VP), Corporate Marketing","linkedInUrl":"https://www.linkedin.com/in/aliahdavismchenry","photoUrl":"https://crustdata-media.s3.us-east-2.amazonaws.com/person/0db905315856153f9f669118d19e3ae3fbc88600d64e4f4d17be30ab123b7a57.jpg","metaTitle":"At the company for","metaValue":"At the company for 2 years 3 months"}]},"recentAds":null,"funding":{"totalInvestmentUsd":2494194394,"lastRoundType":"post_ipo_debt","lastRoundInvestmentUsd":2487694394,"daysSinceLastFundraise":635,"investors":[],"recentRounds":[{"amountUsd":2487694394,"announcedAt":"2024-06-19","roundType":"post_ipo_debt"},{"amountUsd":6500000,"announcedAt":"2018-02-14","roundType":"grant"}]},"news":[{"article_url":"https://syna.ch/aktuell/novartis-beschaeftigte-protestieren-gegen-stellenabbau","article_title":"Novartis-Beschäftigte protestieren gegen Stellenabbau","article_publish_date":"2025-12-12","article_publisher_name":"syna.ch"},{"article_url":"https://unia.ch/de/schwerpunkte/keine-entlassungen-bei-novartis","article_title":"Petition: Keine Entlassungen bei Novartis!","article_publish_date":"2025-12-05","article_publisher_name":"unia.ch"},{"article_url":"https://www.blick.ch/wirtschaft/kahlschlag-in-stein-ag-novartis-baut-550-jobs-ab-id21370227.html","article_title":"Novartis baut 550 Jobs ab – Tabletten-Produktion gestoppt","article_publish_date":"2025-11-26","article_publisher_name":"Blick"},{"article_url":"https://www.watson.ch/schweiz/wirtschaft/897932108-novartis-stellenabbau-in-stein-ag-herrschen-angst-und-wut","article_title":"«Trifft uns hart»: Nach dem Novartis-Schock herrschen in Stein Angst und Wut","article_publish_date":"2025-11-26","article_publisher_name":"Watson"},{"article_url":"https://insideparadeplatz.ch/2025/11/26/hammerschlag-novartis-abbau-wie-schlimm-wirds/","article_title":"Hammerschlag Novartis-Abbau: Wie schlimm wird’s?","article_publish_date":"2025-11-26","article_publisher_name":"Inside Paradeplatz"},{"article_url":"https://www.srf.ch/news/schweiz/stellenabbau-bei-pharmakonzern-novartis-streicht-550-stellen-in-stein-ag","article_title":"Novartis streicht 550 Stellen in Stein AG","article_publish_date":"2025-11-25","article_publisher_name":"Schweizer Radio und Fernsehen"},{"article_url":"https://www.tagesanzeiger.ch/stein-ag-novartis-baut-550-stellen-bis-ende-2027-ab-109821862953","article_title":"Novartis baut im Aargau 550 Stellen ab – «völlig unabhängig» vom US-Ausbau","article_publish_date":"2025-11-25","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.workzeitung.ch/2025/11/550-festangestellte-und-100-temporaere-von-novartis-bangen-um-ihre-jobs/","article_title":"550 Festangestellte und 100 Temporäre von Novartis bangen um ihre Jobs","article_publish_date":"2025-11-25","article_publisher_name":"workzeitung.ch"},{"article_url":"https://www.watson.ch/schweiz/wirtschaft/835074413-novartis-stein-ag-politiker-reagieren-zum-stellenabbau","article_title":"«Absurde Industriepolitik fürs Ausland»: Wermuth tobt wegen Novartis-Entlassungen","article_publish_date":"2025-11-25","article_publisher_name":"Watson"},{"article_url":"https://www.blick.ch/wirtschaft/zoff-um-novartis-kahlschlag-gewerkschaft-wirft-pharmamulti-wortbruch-vor-id21455665.html","article_title":"550 Jobs fallen weg: Hat Novartis ihr Wort gebrochen?","article_publish_date":"2025-11-25","article_publisher_name":"Blick"},{"article_url":"https://www.nzz.ch/wirtschaft/novartis-will-bis-2027-rund-550-stellen-in-der-schweiz-abbauen-ld.1913388","article_title":"Novartis streicht 550 Stellen. Es ist das vierte grosse Abbauprogramm in nur sieben Jahren","article_publish_date":"2025-11-25","article_publisher_name":"Neue Zürcher Zeitung"},{"article_url":"https://www.cash.ch/news/top-news/novartis-stellt-am-investorentag-weiteres-wachstum-in-aussicht-aktie-steigt-883150","article_title":"Novartis stellt am Investorentag weiteres Wachstum in Aussicht - Aktie steigt","article_publish_date":"2025-11-20","article_publisher_name":"Cash"},{"article_url":"https://www.fuw.ch/hoehere-preise-fuer-medikamente-das-vorgehen-von-novartis-kommt-einer-erpressung-gleich-844522076233","article_title":"Höhere Preise für Medikamente: Das Vorgehen von Novartis kommt einer Erpressung gleich","article_publish_date":"2025-11-20","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.tagesanzeiger.ch/novartis-droht-teure-medikamente-nur-noch-fuer-selbstzahler-994883051535","article_title":"So will Novartis in der Schweiz die Medikamentenpreise erhöhen","article_publish_date":"2025-11-20","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.handelszeitung.ch/newsticker/novartis-stellt-am-investorentag-weiteres-wachstum-in-aussicht-883167-1","article_title":"Novartis stellt am Investorentag weiteres Wachstum in Aussicht","article_publish_date":"2025-11-20","article_publisher_name":"Handelszeitung"},{"article_url":"https://www.tagesanzeiger.ch/novartis-neue-produktionsanlagen-in-north-carolina-geplant-378277701812","article_title":"Novartis baut neues Produktionszentrum in North Carolina","article_publish_date":"2025-11-19","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.blick.ch/wirtschaft/das-freut-donald-trump-novartis-baut-mega-fabrik-in-den-usa-700-neue-jobs-id21438459.html","article_title":"Novartis baut Mega-Fabrik in den USA – 700 neue Jobs","article_publish_date":"2025-11-19","article_publisher_name":"Blick"},{"article_url":"https://www.cash.ch/news/top-news/novartis-produziert-kunftig-in-north-carolina-im-grossen-stil-883064","article_title":"Novartis produziert künftig in North Carolina im grossen Stil","article_publish_date":"2025-11-19","article_publisher_name":"Cash"},{"article_url":"https://www.fuw.ch/novartis-erzielt-forschungserfolg-in-malaria-bekaempfung-536967734838","article_title":"Einschätzung: Novartis testet erfolgreich neuartiges Malariamittel","article_publish_date":"2025-11-13","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.cash.ch/news/novartis-erzielt-forschungserfolg-in-malaria-bekampfung-880719","article_title":"Novartis erzielt Forschungserfolg in Malaria-Bekämpfung","article_publish_date":"2025-11-12","article_publisher_name":"Cash"},{"article_url":"https://www.bzbasel.ch/basel/basel-stadt/novartis-reisst-luecke-in-die-rheinfront-ld.4044080","article_title":"Novartis reisst Lücke in die Rheinfront – Ersatz ist nicht in Sicht","article_publish_date":"2025-11-12","article_publisher_name":"bz Basel"},{"article_url":"https://www.cash.ch/news/top-news/novartis-eroffnet-produktion-im-kalifornischen-carlsbad-879759","article_title":"Novartis eröffnet Produktion im kalifornischen Carlsbad","article_publish_date":"2025-11-10","article_publisher_name":"Cash"},{"article_url":"https://www.cash.ch/news/top-news/ist-die-aktie-von-novartis-zu-tief-gefallen-877770","article_title":"Novartis-Aktie: Kurssturz übertrieben oder Einstiegssignal?","article_publish_date":"2025-11-06","article_publisher_name":"Cash"},{"article_url":"https://www.fuw.ch/novartis-waechst-weiter-aber-tempo-laesst-nach-523636260199","article_title":"FuW-Ersteinschätzung zu den Quartalszahlen: Novartis’ Erfolgsserie nimmt ein Ende","article_publish_date":"2025-10-28","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.nzz.ch/wirtschaft/verunsicherte-anleger-novartis-aktie-taucht-nach-quartalszahlen-ld.1909029","article_title":"Verunsicherte Anleger: Novartis-Aktie taucht nach Quartalszahlen","article_publish_date":"2025-10-28","article_publisher_name":"Neue Zürcher Zeitung"},{"article_url":"https://www.cash.ch/news/top-news/novartis-stellt-trotz-generika-delle-weiteres-wachstum-in-aussicht-875507","article_title":"Novartis stellt trotz Generika-Delle weiteres Wachstum in Aussicht","article_publish_date":"2025-10-28","article_publisher_name":"Cash"},{"article_url":"https://www.20min.ch/story/pharmakonzern-novartis-steigert-gewinn-im-dritten-quartal-deutlich-103441416","article_title":"Novartis glänzt mit Quartalszahlen – Gewinn pro Aktie +29 %","article_publish_date":"2025-10-28","article_publisher_name":"20 Minuten"},{"article_url":"https://www.tagesanzeiger.ch/novartis-basel-wachstum-im-q3-verlangsamt-sich-770335732788","article_title":"Zahlen des Pharma-Riesen: Novartis wächst weiter, aber das Tempo lässt nach","article_publish_date":"2025-10-28","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.tagesanzeiger.ch/novartis-groesster-zukauf-seit-jahrzehnten-fuer-12-milliarden-473877651828","article_title":"Novartis’ Megadeal zeigt, warum Big Pharma ständig zukaufen muss","article_publish_date":"2025-10-27","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.fuw.ch/novartis-uebernahme-von-us-biotechfirma-avidity-fuer-12-mrd-359695105340","article_title":"Novartis kündigt grösste Übernahme unter CEO Vas Narasimhan an","article_publish_date":"2025-10-27","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.srf.ch/audio/regionaljournal-basel-baselland/novartis-kauft-ein-biotech-unternehmen-fuer-12-mia-us-dollar?id=AUDI20251027_NR_0048","article_title":"Novartis kauft ein Biotech-Unternehmen für 12 Mia. US-Dollar","article_publish_date":"2025-10-27","article_publisher_name":"Schweizer Radio und Fernsehen"},{"article_url":"https://www.nzz.ch/wirtschaft/novartis-gibt-groesste-uebernahme-seit-einem-jahrzehnt-bekannt-ld.1908862","article_title":"Novartis wagt grösste Übernahme seit zehn Jahren – neue Hoffnung für RNA-Therapien","article_publish_date":"2025-10-27","article_publisher_name":"Neue Zürcher Zeitung"},{"article_url":"https://www.cash.ch/news/top-news/novartis-starkt-mit-grosstem-zukauf-seit-2014-das-geschaft-mit-muskelkrankheiten-anleger-reagieren-verhalten-874732","article_title":"Novartis stärkt mit grösstem Zukauf seit 2014 das Geschäft mit Muskelkrankheiten - Anleger reagieren verhalten","article_publish_date":"2025-10-27","article_publisher_name":"Cash"},{"article_url":"https://www.blick.ch/wirtschaft/zugang-zu-neuen-therapien-novartis-plant-milliardenuebernahme-in-usa-id21362574.html","article_title":"Novartis plant Milliardenübernahme in USA","article_publish_date":"2025-10-26","article_publisher_name":"Blick"},{"article_url":"https://www.srf.ch/news/wirtschaft/avidity-biosciences-novartis-will-us-biotech-firma-fuer-12-milliarden-dollar-kaufen","article_title":"Avidity Biosciences - Novartis will US-Biotech-Firma für 12 Milliarden Dollar kaufen","article_publish_date":"2025-10-26","article_publisher_name":"Schweizer Radio und Fernsehen"},{"article_url":"https://www.fuw.ch/novartis-erreicht-fortschritte-bei-schuppenflechtemittel-536414011750","article_title":"Novartis erreicht Fortschritte bei Schuppenflechtemittel","article_publish_date":"2025-10-22","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.cash.ch/news/top-news/novartis-erhalt-freigabe-fur-ubernahmeangebot-an-tourmaline-bio-873237","article_title":"Novartis erhält Freigabe für Übernahmeangebot an Tourmaline Bio","article_publish_date":"2025-10-22","article_publisher_name":"Cash"},{"article_url":"https://www.fuw.ch/novartis-und-roche-erzielen-bei-scemblix-und-gazyva-zulassungerfolge-in-der-eu-454185843637","article_title":"Novartis und Roche erzielen bei Scemblix und Gazyva Zulassungerfolge in der EU","article_publish_date":"2025-10-17","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.cash.ch/news/top-news/novartis-mittel-kisqali-wirkt-auch-jahre-nach-therapie-gegen-krebsruckfalle-872088","article_title":"Novartis-Mittel Kisqali wirkt auch Jahre nach Therapie gegen Krebsrückfälle","article_publish_date":"2025-10-17","article_publisher_name":"Cash"},{"article_url":"https://basellive.ch/event/v7ZqgdZQ","article_title":"Mittagsführung: NOVARTIS CAMPUS","article_publish_date":"2025-10-17","article_publisher_name":"BaselLive"},{"article_url":"https://www.cash.ch/news/top-news/ist-das-kurspotenzial-bei-den-novartis-valoren-ausgeschopft-871075","article_title":"Vontobel stuft Novartis-Aktie neu mit «Hold» ein – Das sind die Gründe","article_publish_date":"2025-10-15","article_publisher_name":"Cash"},{"article_url":"https://www.cash.ch/news/top-news/novartis-ernennt-neuen-deutschland-chef-868597","article_title":"Novartis ernennt neuen Deutschland-Chef","article_publish_date":"2025-10-07","article_publisher_name":"Cash"},{"article_url":"https://www.fuw.ch/novartis-fda-zulassung-fuer-nesselsucht-medikament-rhapsido-709706905733","article_title":"Rhapsido: Novartis erhält FDA-Zulassung für Nesselsuchtmittel","article_publish_date":"2025-10-01","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.tagesanzeiger.ch/trump-nachgegeben-novartis-senkt-cosentyx-kosten-in-usa-334778808441","article_title":"Novartis gibt Trump nach und verbilligt eines seiner Bestseller-Medikamente in den USA","article_publish_date":"2025-09-30","article_publisher_name":"Tages-Anzeiger"},{"article_url":"https://www.fuw.ch/novartis-cosentyx-direkt-an-us-patienten-mit-55-rabatt-940634635427","article_title":"Direct-to-Patient-Plattform: Novartis startet Direktvertrieb für Top-Medikament Cosentyx in den USA","article_publish_date":"2025-09-29","article_publisher_name":"Finanz und Wirtschaft"},{"article_url":"https://www.cash.ch/news/top-news/novartis-will-seinen-kassenschlager-cosentyx-kunftig-direkt-vermarkten-865980","article_title":"Novartis will seinen Kassenschlager Cosentyx künftig direkt vermarkten","article_publish_date":"2025-09-29","article_publisher_name":"Cash"},{"article_url":"https://www.marketscreener.com/news/u-s-pharma-tariff-a-significant-concern-to-singapore-says-top-official-ce7d5bdade89f226","article_title":"U.S. Pharma Tariff a 'Significant Concern' to Singapore, Says Top Official","article_publish_date":"2025-09-29","article_publisher_name":"MarketScreener"},{"article_url":"https://www.benzinga.com/news/health-care/25/09/47925052/pharmas-direct-to-patient-wave-hits-novartis-next","article_title":"Pharma's Direct-To-Patient Wave Hits Novartis Next","article_publish_date":"2025-09-29","article_publisher_name":"Benzinga.com"},{"article_url":"https://www.marketscreener.com/news/novartis-announces-commencement-of-tender-offer-to-acquire-tourmaline-bio-ce7d5bdbd889f625","article_title":"Novartis announces commencement of tender offer to acquire Tourmaline Bio","article_publish_date":"2025-09-29","article_publisher_name":"MarketScreener"},{"article_url":"https://www.marketscreener.com/news/novartis-to-launch-direct-to-patient-platform-for-cosentyx-in-u-s-ce7d5bdbd881f12d","article_title":"Novartis to Launch Direct-to-Patient Platform for Cosentyx in U.S.","article_publish_date":"2025-09-29","article_publisher_name":"MarketScreener"},{"article_url":"https://www.prnewswire.com/news-releases/regenxbio-announces-presentation-at-the-world-muscle-society-302569161.html","article_title":"REGENXBIO Announces Presentation at the World Muscle Society","article_publish_date":"2025-09-29","article_publisher_name":"PR Newswire"},{"article_url":"https://www.marketscreener.com/news/novartis-announces-commencement-of-tender-offer-to-acquire-tourmaline-bio-ce7d5bdbd889f121","article_title":"Novartis announces commencement of tender offer to acquire Tourmaline Bio","article_publish_date":"2025-09-29","article_publisher_name":"MarketScreener"},{"article_url":"https://www.pharmiweb.com/press-release/2025-09-29/dhealth-intelligence-launches-revolutionary-ai-agent-that-transforms-personal-healthcare-management","article_title":"dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management","article_publish_date":"2025-09-29","article_publisher_name":"PharmiWeb"},{"article_url":"https://www.marketscreener.com/news/novartis-to-launch-us-direct-to-patient-platform-for-cosentyx-ce7d5bdbda88f724","article_title":"Novartis to Launch US Direct-to-Patient Platform for Cosentyx","article_publish_date":"2025-09-29","article_publisher_name":"MarketScreener"},{"article_url":"https://www.morningstar.com/news/dow-jones/202509297864/dow-jones-top-company-headlines-at-1-pm-et-electronic-arts-goes-private-for-55-billion-in-largest-lbo-ever-comcast","article_title":"Dow Jones Top Company Headlines at 1 PM ET: Electronic Arts Goes Private for $55 Billion in Largest LBO Ever | Comcast ...","article_publish_date":"2025-09-29","article_publisher_name":"Morningstar.com"},{"article_url":"https://www.einpresswire.com/article/853462098/united-states-cancer-therapeutics-market-to-hit-491-6-billion-by-2032-driven-by-precision-and-immunotherapy-advances","article_title":"United States Cancer Therapeutics Market to Hit $491.6 Billion by 2032, Driven by Precision and Immunotherapy Advances","article_publish_date":"2025-09-29","article_publisher_name":"EIN Presswire"},{"article_url":"https://www.tradingview.com/news/tradingview:b02d8a2200f17:0-key-facts-novartis-will-invest-23-billion-to-build-and-expand-10-u-s-facilities-over-five-years-including-six-new-plants-and-an-expanded-san-diego-site-creating-over-1-000-jobs/","article_title":"Key facts: Novartis will invest $23 billion to build and expand 10 U.S. facilities over five years, including six new plants and an expanded San Diego site, creating over 1,000 jobs.","article_publish_date":"2025-09-27","article_publisher_name":"TradingView"},{"article_url":"https://www.srf.ch/news/international/usa/us-zollpolitik-trump-kuendigt-100-prozent-pharmazoelle-an-novartis-optimistisch","article_title":"US-Zollpolitik - Trump kündigt 100-Prozent-Pharmazölle an – Novartis optimistisch","article_publish_date":"2025-09-26","article_publisher_name":"Schweizer Radio und Fernsehen"},{"article_url":"https://www.cash.ch/news/top-news/novartis-erwartet-keine-auswirkungen-durch-us-zolle-865347","article_title":"Novartis erwartet keine Auswirkungen durch US-Zölle","article_publish_date":"2025-09-26","article_publisher_name":"Cash"},{"article_url":"https://www.cityam.com/trump-slaps-100-per-cent-tariff-on-imported-drugs/","article_title":"Trump slaps 100 per cent tariff on imported drugs","article_publish_date":"2025-09-26","article_publisher_name":"City A.M."},{"article_url":"https://www.investing.com/news/stock-market-news/european-pharma-shares-drop-after-trump-threatens-more-tariffs-4256819","article_title":"European pharma shares drop after Trump threatens more tariffs","article_publish_date":"2025-09-26","article_publisher_name":"Investing.com"},{"article_url":"https://www.morningstar.com/news/pr-newswire/20250926dc84525/the-american-cancer-society-and-national-football-leagues-nfl-crucial-catch-initiative-works-to-improve-cancer-screening-rates","article_title":"The American Cancer Society and National Football League's (NFL) Crucial Catch Initiative Works to Improve Cancer Screening Rates","article_publish_date":"2025-09-26","article_publisher_name":"Morningstar.com"},{"article_url":"https://www.globenewswire.com/news-release/2025/09/26/3157136/0/en/Spherix-Global-Insights-Highlights-Patient-Influence-in-Shaping-PNH-Treatment-Choices.html","article_title":"Spherix Global Insights Highlights Patient Influence in Shaping PNH Treatment Choices","article_publish_date":"2025-09-26","article_publisher_name":"Spherix Global Insights"},{"article_url":"https://www.globenewswire.com/news-release/2025/09/26/3156978/0/en/Amneal-Announces-BLA-Submission-of-Biosimilar-Candidate-to-XOLAIR-omalizumab.html","article_title":"Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)","article_publish_date":"2025-09-26","article_publisher_name":"Amneal Pharmaceuticals LLC"},{"article_url":"https://www.morningstar.com/news/marketwatch/20250926145/trump-announces-100-tariffs-on-pharmaceuticals-unless-drug-makers-are-building-us-factories","article_title":"Trump announces 100% tariffs on pharmaceuticals unless drug makers are building U.S. factories","article_publish_date":"2025-09-26","article_publisher_name":"Morningstar.com"},{"article_url":"https://www.marketscreener.com/news/novartis-to-showcase-transformative-data-in-advanced-prostate-and-early-breast-cancer-at-esmo-2025-ce7d58d3dc8cf125","article_title":"Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025","article_publish_date":"2025-09-26","article_publisher_name":"MarketScreener"},{"article_url":"https://www.tradingview.com/news/reuters.com,2025:newsml_L3N3VD0SB:0-global-drugmakers-rush-to-boost-us-presence-as-tariff-threat-looms/","article_title":"Global drugmakers rush to boost US presence as tariff threat looms","article_publish_date":"2025-09-26","article_publisher_name":"Reuters"},{"article_url":"https://www.prnewswire.com/news-releases/the-american-cancer-society-and-national-football-leagues-nfl-crucial-catch-initiative-works-to-improve-cancer-screening-rates-302568427.html","article_title":"The American Cancer Society and National Football League's (NFL) Crucial Catch Initiative Works to Improve Cancer Screening Rates","article_publish_date":"2025-09-26","article_publisher_name":"PR Newswire"},{"article_url":"https://www.cash.ch/news/top-news/novartis-sieht-wirksamkeit-von-ms-mittel-durch-neue-daten-untermauert-864415","article_title":"Novartis sieht Wirksamkeit von MS-Mittel durch neue Daten untermauert","article_publish_date":"2025-09-24","article_publisher_name":"Cash"},{"article_url":"https://www.marketscreener.com/news/novartis-says-new-data-further-support-benefits-of-kesimpta-ce7d58dddc80f624","article_title":"Novartis says new data further support benefits of Kesimpta","article_publish_date":"2025-09-24","article_publisher_name":"MarketScreener"},{"article_url":"https://www.marketscreener.com/news/novartis-kesimpta-achieves-new-positive-results-in-multiple-sclerosis-ce7d58dddf81fe26","article_title":"Novartis' Kesimpta achieves new positive results in multiple sclerosis","article_publish_date":"2025-09-24","article_publisher_name":"MarketScreener"},{"article_url":"https://www.marketscreener.com/news/novartis-announces-new-data-from-two-kesimpta-studies-in-relapsing-multiple-sclerosis-ce7d58dddf8af226","article_title":"Novartis Announces New Data from Two Kesimpta®? Studies in Relapsing Multiple Sclerosis","article_publish_date":"2025-09-24","article_publisher_name":"MarketScreener"},{"article_url":"https://www.morningstar.com/news/pr-newswire/20250924ny81348/new-novartis-data-further-support-benefits-of-kesimpta-in-relapsing-ms-following-switch-from-oral-disease-modifying-therapies","article_title":"New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies","article_publish_date":"2025-09-24","article_publisher_name":"Morningstar.com"},{"article_url":"https://www.prnewswire.com/news-releases/ai-in-oncology-for-analytical-solutions-market-size--share-to-surpass-8-86-billion-by-2035--growing-at-a-cagr-21--vantage-market-research-302564188.html","article_title":"AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research","article_publish_date":"2025-09-23","article_publisher_name":"PR Newswire"},{"article_url":"https://www.prnewswire.co.uk/news-releases/ai-in-oncology-for-analytical-solutions-market-size--share-to-surpass-8-86-billion-by-2035--growing-at-a-cagr-21--vantage-market-research-302564193.html","article_title":"AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research","article_publish_date":"2025-09-23","article_publisher_name":"PR Newswire UK"},{"article_url":"https://www.einpresswire.com/article/851658671/dysmenorrhea-treatment-market-size-forecast-growth-analysis-industry-trends-key-players-2024-2032","article_title":"Dysmenorrhea Treatment Market Size, Forecast, Growth, Analysis, Industry Trends & Key Players 2024-2032","article_publish_date":"2025-09-23","article_publisher_name":"EIN Presswire"},{"article_url":"https://www.investing.com/news/stock-market-news/us-fda-declines-to-approve-higherdose-of-biogens-genetic-disorder-drug-4252139","article_title":"US FDA declines to approve higher dose of Biogen’s genetic disorder drug","article_publish_date":"2025-09-23","article_publisher_name":"Investing.com"},{"article_url":"https://www.globenewswire.com/news-release/2025/09/23/3154634/0/en/Cyclosporine-Market-Size-to-Hit-USD-9-44-Billion-by-2032-Driven-by-Rising-Organ-Transplants-and-Expanding-Therapeutic-Applications-S-S-Insider.html","article_title":"Cyclosporine Market Size to Hit USD 9.44 Billion by 2032, Driven by Rising Organ Transplants and Expanding Therapeutic Applications | S&S Insider","article_publish_date":"2025-09-23","article_publisher_name":"SNS Insider pvt ltd"},{"article_url":"https://www.watson.ch/schweiz/wirtschaft/927647680-zoff-um-medikamentenpreise-in-der-schweiz-novartis-viel-zu-tief","article_title":"Novartis-CEO: «Medikamentenpreise in der Schweiz viel zu tief» – «Gegenteil ist der Fall»","article_publish_date":"2025-09-22","article_publisher_name":"Watson"},{"article_url":"https://www.benzinga.com/markets/large-cap/25/09/47801165/roche-targets-top-spot-in-weight-loss-drug-market","article_title":"Roche Targets Top Spot In Weight Loss Drug Market","article_publish_date":"2025-09-22","article_publisher_name":"Benzinga.com"},{"article_url":"https://www.biospace.com/business/novartis-looking-for-constructive-ways-to-bring-down-drug-costs-in-us","article_title":"Novartis Looking for Constructive Ways to Bring Down Drug Costs in US","article_publish_date":"2025-09-22","article_publisher_name":"BioSpace"},{"article_url":"https://www.prnewswire.com/news-releases/rna-based-therapies-market-to-reach-usd-213-54-billion-by-2033--driven-by-rare-diseases-oncology-and-advances-in-rna-technologies--datam-intelligence-302563107.html","article_title":"RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence","article_publish_date":"2025-09-22","article_publisher_name":"PR Newswire"},{"article_url":"https://www.globenewswire.com/news-release/2025/09/22/3153692/28124/en/Growth-Opportunities-in-the-Immuno-oncology-Therapeutics-Market-2024-2030-Advances-in-Next-Gen-Immunotherapies-AI-and-Biomarker-Driven-Personalization-are-Driving-Transformational-.html","article_title":"Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth","article_publish_date":"2025-09-22","article_publisher_name":"Research and Markets"},{"article_url":"https://www.benzinga.com/news/health-care/25/09/47790474/novartis-builds-us-drug-reserves-against-potential-tariffs","article_title":"Novartis Builds US Drug Reserves Against Potential Tariffs","article_publish_date":"2025-09-22","article_publisher_name":"Benzinga.com"},{"article_url":"https://www.prnewswire.co.uk/news-releases/rna-based-therapies-market-to-reach-usd-213-54-billion-by-2033--driven-by-rare-diseases-oncology-and-advances-in-rna-technologies--datam-intelligence-302563110.html","article_title":"RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence","article_publish_date":"2025-09-22","article_publisher_name":"PR Newswire UK"},{"article_url":"https://www.globenewswire.com/news-release/2025/09/22/3154196/0/en/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLC-Investigates-WOW-PRO-TRML-PGRE-on-Behalf-of-Shareholders.html","article_title":"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WOW, PRO, TRML, PGRE on Behalf of Shareholders","article_publish_date":"2025-09-22","article_publisher_name":"Halper Sadeh LLC"},{"article_url":"https://www.swissinfo.ch/ger/innovationen-im-gesundheitswesen/wie-novartis-einen-unglaublichen-durchbruch-in-der-krebsforschung-erzielte/89972746","article_title":"Novartis erzielt aufsehenerregenden Durchbruch in der Krebsforschung","article_publish_date":"2025-09-21","article_publisher_name":"SWI swissinfo.ch"},{"article_url":"https://thefly.com/permalinks/entry.php/id4200896/NVS-Novartis-increased-its-stockpiles-of-pharmaceuticals-in-the-US-Reuters-says1758488840C99","article_title":"Novartis increased its stockpiles of pharmaceuticals in the U.S., Reuters says","article_publish_date":"2025-09-21","article_publisher_name":"thefly.com"},{"article_url":"https://www.marketscreener.com/news/swiss-pharma-novartis-mulls-options-to-reduce-us-drug-prices-ce7d58ded08af420","article_title":"Swiss Pharma Novartis Mulls Options to Reduce US Drug Prices","article_publish_date":"2025-09-21","article_publisher_name":"MarketScreener"},{"article_url":"https://thefly.com/permalinks/entry.php/id4200888/NVS-Novartis-looking-into-price-cut-proposals-for-US-Bloomberg-reports1758473332C99","article_title":"Novartis looking into price cut proposals for U.S., Bloomberg reports","article_publish_date":"2025-09-21","article_publisher_name":"thefly.com"},{"article_url":"https://www.nzz.ch/wirtschaft/in-der-schweiz-sind-die-medikamentenpreise-viel-zu-tief-sagt-der-novartis-chef-ld.1903231","article_title":"«In der Schweiz sind die Medikamentenpreise viel zu tief», sagt der Novartis-Chef","article_publish_date":"2025-09-20","article_publisher_name":"Neue Zürcher Zeitung"},{"article_url":"https://www.watson.ch/schweiz/pharma/817960722-novartis-will-preisunterschied-von-arzneien-zu-den-usa-eliminieren","article_title":"Schweizer Arzneien-Preise «viel zu tief»: Novartis will Unterschied zu den USA eliminieren","article_publish_date":"2025-09-20","article_publisher_name":"Watson"},{"article_url":"https://www.20min.ch/story/pharmaindustrie-druck-von-trump-novartis-will-medi-preise-in-der-schweiz-erhoehen-103418818","article_title":"Novartis: Preissenkungen in den USA werden geprüft","article_publish_date":"2025-09-20","article_publisher_name":"20 Minuten"},{"article_url":"https://www.blick.ch/wirtschaft/muss-die-schweiz-dafuer-bluten-novartis-will-medikamente-in-den-usa-verguenstigen-id21249214.html","article_title":"Novartis-Chef will Medikamente in den USA vergünstigen","article_publish_date":"2025-09-20","article_publisher_name":"Blick"},{"article_url":"https://www.bazonline.ch/novartis-vas-narasimhan-fuer-hoehere-medikamentenpreise-738420650745","article_title":"«Schweizer zahlen viel zu wenig»: Novartis-CEO für teurere Medikamente","article_publish_date":"2025-09-20","article_publisher_name":"Basler Zeitung"},{"article_url":"https://www.ibtimes.com/novartis-chief-eyes-ways-end-higher-us-drug-prices-media-3784031","article_title":"Novartis Chief Eyes Ways To End Higher US Drug Prices: Media","article_publish_date":"2025-09-20","article_publisher_name":"International Business Times"},{"article_url":"https://finance.yahoo.com/news/novartis-stockpiles-withstand-potential-trump-100031164.html","article_title":"Novartis has stockpiles to withstand potential Trump tariffs, CEO says","article_publish_date":"2025-09-20","article_publisher_name":"Yahoo Finance"},{"article_url":"https://www.marketscreener.com/news/novartis-has-stockpiles-to-withstand-potential-trump-tariffs-ceo-says-ce7d58ded18af127","article_title":"Novartis has stockpiles to withstand potential Trump tariffs, CEO says","article_publish_date":"2025-09-20","article_publisher_name":"MarketScreener"},{"article_url":"https://www.investing.com/news/stock-market-news/novartis-has-stockpiles-to-withstand-potential-trump-tariffs-ceo-says-4247708","article_title":"Novartis has stockpiles to withstand potential Trump tariffs, CEO says","article_publish_date":"2025-09-20","article_publisher_name":"Investing.com"},{"article_url":"https://en.ain.ua/2025/09/19/doctorone-raises-eur4m/","article_title":"Polish healthtech startup Doctor.One raises €4M seed round to expand across Europe","article_publish_date":"2025-09-19","article_publisher_name":"ain.ua"}]},"variant":"list","hasBorder":true,"logoPriority":true}],"$L4b"]}],"$L4c"]}],"$L4d"]}],null]}]}]}] 50:T41a7,THE ROLE. Search is fragmented. Discovery no longer starts or ends with Google. Buyers research across AI tools, social platforms, publishers, review sites and communities before they ever return to a traditional results page. Search is now one discipline across Google and AI answers, and the brands that win are the ones that are visible, cited and recommended wherever their audience is looking. GEO is now central to how clients win in search, and it is the heart of this role. As Search Account Director at Found, you will lead GEO and SEO delivery across a portfolio of complex client accounts and own the senior client relationships behind them. You will own complex enterprise client relationships, where strategy spans multiple markets, products and teams. You will bring a strong grounding in SEO, built through leading teams and accounts, and use it to drive how clients are found, cited and trusted in AI answers, while keeping their search foundations strong. You will champion a modern search approach that works with Found Media and Found Social to keep brand messaging consistent, and build a unified strategy across AI platforms, search engines and social by combining GEO, Technical SEO and UX, multimodal content, topical and brand authority, and Digital PR. You will sit within the Found Search team, line managing Search Account Manager(s) and Senior Search Executive(s). You will coordinate delivery across GEO, Technical SEO, Content, Digital PR and CRO within Found Search, and bring in Found Studio and Found Influence so that content, PR and creator work run against a single plan. Beyond account delivery, you will shape best practice, drive innovation and influence how Found Search operates across the agency in an AI-driven, multi-platform world. IMPACT OF THE ROLE Your work will directly contribute to: - Strategic and Commercial Leadership: Guiding modern search strategy across a client portfolio with a sharp focus on KPIs, ROI and long-term growth, with AI visibility at the centre. - Visibility Across All Platforms: Treating AI visibility and rankings as one picture, across AI answers, Google and the third-party sources AI draws on, such as YouTube and Reddit. - Client Success and Retention: Acting as the senior point of contact to build deep, productive client relationships and identify upsell opportunities. - Team Performance and Development: Leading, developing and nurturing Account Managers and Executives, ensuring high standards and career growth. - Operational Excellence: Ensuring all accounts are delivered efficiently, meeting strategic goals, budget parameters and best practice benchmarks. - Integrated Marketing Strategy: Championing cross-channel collaboration to deliver unified client strategies across Found Search, Found Media and Found Data & AI. - Innovation and Leadership in GEO: Staying at the forefront of GEO as it develops, and embedding what works into best practice so clients stay ahead. KEY RESPONSIBILITIES ACCOUNT LEADERSHIP - Build and maintain strong, trusted relationships with senior client stakeholders, acting as their strategic partner for the future of search. - Act as the final escalation point and accountable owner for portfolio commercials, ensuring Search Account Managers have clear direction for day-to-day delivery and client communications. - Lead key meetings and contribute to QBRs, proposals and client development planning. - Ensure reporting, forecasting and delivery standards across your portfolio are consistently high, commercially sound and trusted by clients. - Own portfolio resourcing, ensuring the right people are allocated at the right time across accounts. GEO & AI VISIBILITY - Own GEO as the core of the strategy on every account: how a client is visible, cited and recommended in AI answers, and how it is described when it appears. - Build audience and prompt research that reflects who is asking and what they ask, then track visibility, citations, sentiment and AI referral traffic against it. - Identify the owned content, third-party sources and technical gaps that determine AI visibility, and turn them into a prioritised plan across Found Search, Found Studio and Found Influence. - Use SEO strength as the foundation, so that rankings, technical health and content performance support AI visibility and the other way round. - Stay at the forefront of GEO as AI platforms change, refining methodology and scaling what works across accounts. STRATEGY - Define and own the search strategy across your portfolio, building holistic roadmaps that target user intent across AI platforms, search engines and social. - Prioritise opportunities using measured data combined with expert judgement, and defend those calls when clients challenge them. - Ensure performance frameworks are set across AI visibility, search and social surfaces (KPIs, reporting, review cadence), monitoring outcomes and pivoting strategy when needed. - Guide teams to implement and validate strategy, ensuring outcomes are measurable and impactful. - Work with development teams from the start of a brief on structured data and crawler readiness, rather than as a late request. - Collaborate with Found Media and Found Social to maximise visibility and ensure consistent brand messaging. COMMERCIAL MANAGEMENT - Manage the profitability of your portfolio, ensuring strict adherence to scope and budget. - Proactively identify opportunities to grow the account (upsell and cross-sell) by spotting gaps in the client’s AI and search presence. - Lead the commercial side of renewals and annual planning, ensuring the value of the work is clearly linked to the client’s business goals. - Support accurate scoping and resourcing for new initiatives (including GEO programmes), ensuring plans are deliverable within budget and timelines. - Present and defend strategy and diagnostic findings directly to clients and prospects, including when challenged live. - Support wider agency growth by contributing to pitches and developing commercially viable strategy proposals for prospective clients. TEAM MANAGEMENT - Line manage and coach Search Account Managers and Executives, setting clear expectations and goals. - Conduct weekly 1:1s and quarterly development sessions, and manage performance against personal development plans (PDPs). - Support your team’s growth by reviewing outputs, delivering feedback and providing stretch opportunities, including building the team’s GEO skills. - Act as a mentor and department leader, setting the tone for collaboration, knowledge-sharing and performance culture. AI & INNOVATION - Use AI responsibly and ethically in line with company policies, ensuring transparency and trust in its application. - Guide teams in using AI to create efficiencies and automate routine tasks such as audits and reporting, unlocking capacity for higher-value strategic work. - Advocate for AI-enabled practices that strengthen client partnerships and deliver strategic impact. COMPANY RESPONSIBILITIES - Consistently follow company and team processes, ensuring alignment and efficiency across all projects. - Use company platforms (such as Asana, Float and other internal tools) effectively to manage tasks, resources and workflows. - Log time accurately and on schedule, providing transparency and supporting operational planning. - Promote and uphold Found’s values and culture, acting as an inspiring, supportive and accountable team member or leader. - Ensure consistent, high-quality service delivery that enhances Found’s reputation and strengthens client trust. - Maintain an up-to-date understanding of Found’s technology, products and services, and apply them effectively in your role. - Stay informed of industry standards, innovations and emerging approaches in digital marketing, applying relevant insights to client and agency work. BEHAVIOURS IN THIS ROLE - Strategic Thinker: Drives innovation and long-term thinking, aligning client goals with evolving industry trends and anticipating how AI and search will develop to keep Found’s proposition market-leading. - Commercially Astute: Understands the financial implications of client relationships, protecting profitability while actively identifying opportunities for revenue growth. - Influential Communicator: Simplifies complex concepts for senior stakeholders, using data and storytelling to persuade and guide decision-making, and defends recommendations with confidence when challenged. - Strong Leader & Mentor: Inspires, develops and holds the team accountable with empathy and confidence, fostering a culture of high performance. - Collaborative & Cross-Functional: Works seamlessly across teams, breaking down silos to promote integration and shared success. - Curious & Experimental: Actively stays ahead of industry updates and demonstrates curiosity to test and learn, challenging the status quo to find better ways of working. - Solutions-Focused & Adaptable: Leads calmly through change and ambiguity, viewing challenges as opportunities and inspiring the team to take action. WHAT SUCCESS LOOKS LIKE Commercial Performance - Proactively identifies and secures upsell opportunities across the portfolio, directly contributing to wider agency revenue growth. - Supports agency growth by contributing to pitches and developing commercially viable proposals for prospective clients. - Delivers profitable growth, ensuring work is delivered efficiently to balance exceptional client outcomes with healthy agency margins. Strategic Excellence - Delivers measurable gains in AI visibility for clients: presence, citation and sentiment in AI answers, and AI-referred traffic. - Develops and implements modern search strategies that use the full mix of GEO, Technical, Content and Digital PR to deliver measurable performance against client KPIs. - Moves reporting beyond standard SEO metrics, providing a unified view of visibility, traffic and impact across all search platforms, and links visibility to client pipeline or revenue. - Proactively identifies opportunities to position search as a critical driver of business success, ensuring clients stay ahead of the curve. Client Satisfaction & Growth - Builds and sustains long-term client relationships, acting as a trusted partner. - Demonstrates clear evidence of upsell success, retention and client advocacy. - Ensures client goals are consistently exceeded through insight-led recommendations. Team Leadership - Leads and inspires a high-performing Found Search team, fostering a culture of collaboration, accountability and innovation. - Provides mentorship, structured development and career progression opportunities, ensuring direct reports consistently perform at a high level. - Builds GEO capability across the team and encourages continuous learning as the field changes. Operational Efficiency - Ensures accounts are run to best-practice standards, with accurate time usage, clear reporting, strong process discipline and strict adherence to budgets and timelines. - Creates clarity for teams by setting direction and maintaining structured account roadmaps. - Champions scalable ways of working that drive efficiency without sacrificing quality. Departmental Impact - Plays a key role in shaping the culture, practices and growth of Found Search. - Brings thought leadership and innovation to improve processes, positioning the department as best-in-class in GEO. - Actively contributes to agency-wide initiatives and collaborative projects. Cross-Channel Integration - Ensures search strategies work seamlessly alongside Found Media, Found Social, Found Studio, Found Influence and Found Data & AI. - Runs content, digital PR, Found Studio and Found Influence against a single plan rather than separate briefs, and knows when to bring each in and how to brief them. - Demonstrates how integrated thinking has improved efficiency or performance for clients. - Collaborates with sister agencies and Tomorrow Group partners to unlock joint opportunities. EXPERIENCE & PROFILE - A career built in SEO, proven experience in a similar agency role, leading teams and accounts as a pod leader, account lead or equivalent. - Hands-on experience at the forefront of GEO: you are already moving clients or teams into AI visibility, including tracking and improving brand visibility, citations and sentiment in AI answers, and measuring AI referral impact. - Experience managing enterprise accounts across multiple markets, products and stakeholder groups. - Experience owning strategy, commercials and delivery for a high-value account where several internal specialists and external parties contribute. - Experienced in costing projects, creating proposals and managing team allocation to ensure account profitability. - Experience managing senior client governance on complex accounts, including multiple stakeholders, competing priorities and regular executive reporting. - Understands the financial implications of client relationships, protecting profitability while actively identifying opportunities for revenue growth. - Proven ability to define long-term, multi-channel roadmaps that drive measurable business impact across traffic, revenue and brand metrics. - Strong working knowledge of Technical SEO, with experience directing complex initiatives such as site migrations, international SEO and ecommerce websites. - Strong grounding in Content Strategy, with experience shaping content that serves both search engines and AI answers. - Demonstrable experience coordinating Found Media, Found Studio, Found Influence and PR teams against a single plan to drive unified performance and efficiency. - Strong track record of delivering complex projects on time and to budget. You are highly organised, able to oversee multiple workstreams and ensure quality control across all deliverables. - Proven experience in line management, with a track record of developing talent, conducting performance reviews and fostering career growth. - Understands how AI-driven discovery is changing search behaviour, with a strong desire to keep evolving the agency's offering. - Excellent ability to simplify complex search concepts for senior stakeholders, articulating the business value of modern search and AI clearly. PERKS AND BENEFITS - Dynamic, Flexible Working 🏠 – Work is what we do, not where we do it. We believe in having a working environment where we thrive and can do our best work, whether that is at home, in the office or on the beach. - Private Medical Insurance 🧑‍⚕️ – We support your health and wellbeing with either a cash pot or enhanced medical insurance to help with both medical and dental needs. - Financial Wellbeing Coaching 💷 – Access to Bippit which provides access to professionally qualified coaches who assist with household financial accounts, budget monitoring, and creating holistic financial plans for all aspects of life. - 1-1 Counselling & Mental Health Support 🧠 – Supporting your mental health, you will have access to six 1-1 sessions of therapy, plus access to self-directed content and frequent live workshops with Oliva for life. - Subsidised Gym Membership 🤸 – Access to a platform of multiple gyms across the UK. - Enhanced Parental Leave 👶 – We offer competitive packages to support our team with big life changes with up to 6 months enhanced primary caregiver pay and 6 weeks secondary caregiver pay. - Interchangeable Bank Holidays ➡️ – We have a global multicultural team, so everyone gets the choice to swap bank holidays to cultural/religious days that are important to them. - Matchable Partnership 🫶 – Two paid volunteering days via Matchable, a platform that promotes social impact by connecting individuals with meaningful community volunteering opportunities. - Work from Abroad 🌍 – Up to 30 days a year working from another country. - Personalised Career Progression 📝 – We know that progression is highly individual. You'll have a personalised development plan with meaningful, impactful training opportunities. - And lots more! ⭐ At Found, we're passionate about building a team of talented individuals from all walks of life who share the skills and drive to help us achieve our mission. That's why we're committed to a hiring process free from judgment, prejudice, or bias. We encourage everyone to apply for our roles—your gender identity, race, ethnicity, sexual orientation, age, or background will never impact how your application is considered. We're dedicated to fostering an inclusive culture where everyone feels empowered to do their best work, enjoy their journey, and truly feel they belong.51:T1369,

AI Search jobs in the UK

Director AI Search & Visibility

SEARCH ACCOUNT DIRECTOR (SEO & GEO)